279 related articles for article (PubMed ID: 15083501)
1. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee HS; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):275-86. PubMed ID: 11913718
[TBL] [Abstract][Full Text] [Related]
3. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
Kim SH; Kim WB; Lee MG
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):347-62. PubMed ID: 8746482
[TBL] [Abstract][Full Text] [Related]
4. Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Kim YC; Lee JK; Kwon JW; Yoo M; Lee I; Lee MG
Biopharm Drug Dispos; 2006 Apr; 27(3):147-56. PubMed ID: 16408258
[TBL] [Abstract][Full Text] [Related]
5. Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Lee SJ; Kwon JW; Kim WB; Lee MG
J Pharm Pharmacol; 2004 May; 56(5):635-42. PubMed ID: 15142341
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
Lee JH; Shin JH; Lee MG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.
Kim SH; Moon YJ; Ryu CK; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):419-29. PubMed ID: 11589368
[TBL] [Abstract][Full Text] [Related]
8. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
Yang SH; Lee MG
Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
[TBL] [Abstract][Full Text] [Related]
9. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
Yang SH; Lee MG
Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute renal failure on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Kwon JW; Kim WB; Lee I; Lee MG
Biopharm Drug Dispos; 2006 Jan; 27(1):29-37. PubMed ID: 16302289
[TBL] [Abstract][Full Text] [Related]
11. Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.
Bae SK; Kim EJ; Kwon JW; Kim WB; Lee I; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):67-75. PubMed ID: 15617136
[TBL] [Abstract][Full Text] [Related]
12. Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
Chung SY; Han KS; Chung YK; Chang MS; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):187-200. PubMed ID: 9667073
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
[TBL] [Abstract][Full Text] [Related]
15. Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
Kim SH; Han KS; Choi WS; Chang MS; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):77-84. PubMed ID: 9434317
[TBL] [Abstract][Full Text] [Related]
16. Stability, blood partition and protein binding of an antifibrotic agent, oltipraz.
Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):333-44. PubMed ID: 12889516
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats.
Bae SK; Yang SH; Shin KN; Rhee JK; Yoo M; Lee MG
J Pharm Pharmacol; 2007 Jul; 59(7):955-63. PubMed ID: 17637190
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Steinke W; Ahr HJ; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
[TBL] [Abstract][Full Text] [Related]
20. Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
Lee MH; Kim HJ; Kim SH; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):361-70. PubMed ID: 12889527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
